Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

Tobacco withdrawal components and their relations with cessation success.

Piper ME, Schlam TR, Cook JW, Sheffer MA, Smith SS, Loh WY, Bolt DM, Kim SY, Kaye JT, Hefner KR, Baker TB.

Psychopharmacology (Berl). 2011 Aug;216(4):569-78. doi: 10.1007/s00213-011-2250-3. Epub 2011 Mar 18.

2.
3.

Anhedonia: Its Dynamic Relations With Craving, Negative Affect, and Treatment During a Quit Smoking Attempt.

Cook JW, Lanza ST, Chu W, Baker TB, Piper ME.

Nicotine Tob Res. 2017 Jun 1;19(6):703-709. doi: 10.1093/ntr/ntw247.

PMID:
28486709
4.

Negative affect subtypes and craving differentially predict long-term cessation success among smokers achieving initial abstinence.

Zuo Y, Rabinovich NE, Gilbert DG.

Psychopharmacology (Berl). 2017 Mar;234(5):761-771. doi: 10.1007/s00213-016-4509-1. Epub 2016 Dec 27.

PMID:
28028602
5.

Why two smoking cessation agents work better than one: role of craving suppression.

Bolt DM, Piper ME, Theobald WE, Baker TB.

J Consult Clin Psychol. 2012 Feb;80(1):54-65. doi: 10.1037/a0026366. Epub 2011 Nov 21.

6.

A bupropion smoking cessation clinical trial for cancer patients.

Schnoll RA, Martinez E, Tatum KL, Weber DM, Kuzla N, Glass M, Ridge JA, Langer C, Miyamoto C, Wileyto EP, Leone F.

Cancer Causes Control. 2010 Jun;21(6):811-20. doi: 10.1007/s10552-010-9507-8. Epub 2010 Jan 20.

PMID:
20087643
7.

What a difference a day makes: differences in initial abstinence response during a smoking cessation attempt.

Piper ME, Vasilenko SA, Cook JW, Lanza ST.

Addiction. 2017 Feb;112(2):330-339. doi: 10.1111/add.13613. Epub 2016 Oct 28.

8.

Anxiety diagnoses in smokers seeking cessation treatment: relations with tobacco dependence, withdrawal, outcome and response to treatment.

Piper ME, Cook JW, Schlam TR, Jorenby DE, Baker TB.

Addiction. 2011 Feb;106(2):418-27. doi: 10.1111/j.1360-0443.2010.03173.x. Epub 2010 Oct 25.

9.

Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment.

Schnoll RA, Martinez E, Tatum KL, Glass M, Bernath A, Ferris D, Reynolds P.

Addict Behav. 2011 Jan-Feb;36(1-2):144-7. doi: 10.1016/j.addbeh.2010.08.024. Epub 2010 Sep 24.

10.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
11.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
12.

Smoking-specific experiential avoidance cognition: explanatory relevance to pre- and post-cessation nicotine withdrawal, craving, and negative affect.

Farris SG, Zvolensky MJ, Schmidt NB.

Addict Behav. 2015 May;44:58-64. doi: 10.1016/j.addbeh.2014.07.026. Epub 2014 Aug 6.

13.

Incremental efficacy of adding bupropion to the nicotine patch for smoking cessation in smokers with a recent history of alcohol dependence: results from a randomized, double-blind, placebo-controlled study.

Kalman D, Herz L, Monti P, Kahler CW, Mooney M, Rodrigues S, O'Connor K.

Drug Alcohol Depend. 2011 Nov 1;118(2-3):111-8. doi: 10.1016/j.drugalcdep.2011.03.005. Epub 2011 Apr 19.

14.

A randomized clinical trial of nicotine lozenge for smokeless tobacco use.

Ebbert JO, Severson HH, Croghan IT, Danaher BG, Schroeder DR.

Nicotine Tob Res. 2009 Dec;11(12):1415-23. doi: 10.1093/ntr/ntp154. Epub 2009 Oct 30.

15.

Effect of high-dose nicotine patch on craving and negative affect leading up to lapse episodes.

Ferguson SG, Shiffman S.

Psychopharmacology (Berl). 2014 Jul;231(13):2595-602. doi: 10.1007/s00213-013-3429-6. Epub 2014 Jan 10.

PMID:
24408214
16.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD006103.

PMID:
22513936
17.

Effect of stress and bupropion on craving, withdrawal symptoms, and mood in smokers.

Kotlyar M, Drone D, Thuras P, Hatsukami DK, Brauer L, Adson DE, al'Absi M.

Nicotine Tob Res. 2011 Jun;13(6):492-7. doi: 10.1093/ntr/ntr011. Epub 2011 Mar 4.

18.

The effect of bupropion on nicotine craving and withdrawal.

Shiffman S, Johnston JA, Khayrallah M, Elash CA, Gwaltney CJ, Paty JA, Gnys M, Evoniuk G, DeVeaugh-Geiss J.

Psychopharmacology (Berl). 2000 Jan;148(1):33-40.

PMID:
10663415
19.

Within-day temporal patterns of smoking, withdrawal symptoms, and craving.

Chandra S, Scharf D, Shiffman S.

Drug Alcohol Depend. 2011 Sep 1;117(2-3):118-25. doi: 10.1016/j.drugalcdep.2010.12.027. Epub 2011 Feb 15.

20.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T.

Cochrane Database Syst Rev. 2016 May 9;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7. Review.

PMID:
27158893

Supplemental Content

Support Center